Page last updated: 2024-10-27

flumazenil and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

flumazenil has been researched along with Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamashita, Y1
Matsuishi, T1
Ishibashi, M1
Kimura, A1
Onishi, Y1
Yonekura, Y1
Kato, H1

Other Studies

1 other study available for flumazenil and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

ArticleYear
Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome.
    Journal of the neurological sciences, 1998, Feb-05, Volume: 154, Issue:2

    Topics: Adult; Brain; Case-Control Studies; Female; Flumazenil; Humans; Male; Radioligand Assay; Receptors,

1998